Inhalation of tobramycin for the patients with persistent respiratory infection by Psudomonas aeruginosa

Inhalation of tobramycin for the patients with persistent respiratory infection by Psudomonas aeruginosa - Inhalation of tobramycin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002893

Enrollment

Registered

2009-12-14

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent respiratory infection by Pseudomonas aeruginosa

Interventions

Patients with persistent respiratory infection by Pseudomonas aeruginosa that are difficult to be cured with intravenous antibiotics are administered inhaled tobramycin with nebulizer.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with persistent respiratory infection by Pseudomonas aeruginosa that are difficult to be cured with intravenous antibiotics.

Exclusion criteria

Exclusion criteria: Cases with severe respiratory failure that require high density oxygen inhalation.

Design outcomes

Primary

Measure	Time frame
Appearance and amount of airway secretions, culture of airway secretions, body temperature, white blood cell count, titer of CRP, PaO2/FiO2 ratio, and chest radiography	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026